These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1303 related items for PubMed ID: 11032018

  • 1. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 2. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM, Rusyn EV, Zhou H, Sartor CI, Cox AD.
    Cancer Res; 2002 Jul 15; 62(14):4142-50. PubMed ID: 12124353
    [Abstract] [Full Text] [Related]

  • 3. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA, Solski PA, Jillian SA, Pérez de la Ossa P, D'Eustachio P, Der CJ, Rush MG.
    Oncogene; 1999 Jul 01; 18(26):3831-45. PubMed ID: 10445846
    [Abstract] [Full Text] [Related]

  • 4. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR, Abe K, Karnoub AE, Der CJ.
    Mol Cancer Res; 2004 Dec 01; 2(12):702-11. PubMed ID: 15634759
    [Abstract] [Full Text] [Related]

  • 5. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM.
    J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703
    [Abstract] [Full Text] [Related]

  • 6. Ras pathway signals are required for notch-mediated oncogenesis.
    Fitzgerald K, Harrington A, Leder P.
    Oncogene; 2000 Aug 31; 19(37):4191-8. PubMed ID: 10980592
    [Abstract] [Full Text] [Related]

  • 7. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS, Schäfer R, Der CJ.
    Mol Cancer Res; 2003 Dec 31; 1(14):1077-88. PubMed ID: 14707291
    [Abstract] [Full Text] [Related]

  • 8. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 31; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 9. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 10. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.
    Conejo R, de Alvaro C, Benito M, Cuadrado A, Lorenzo M.
    Oncogene; 2002 May 23; 21(23):3739-53. PubMed ID: 12032842
    [Abstract] [Full Text] [Related]

  • 11. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 12. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
    Urich M, Senften M, Shaw PE, Ballmer-Hofer K.
    Oncogene; 1997 Mar 13; 14(10):1235-41. PubMed ID: 9121774
    [Abstract] [Full Text] [Related]

  • 13. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL, Lin MQ, Wang MZ, Yao Z.
    Shi Yan Sheng Wu Xue Bao; 1997 Mar 13; 30(1):73-81. PubMed ID: 10684111
    [Abstract] [Full Text] [Related]

  • 14. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA, Zhou Y, Morita S, Der CJ.
    Mol Carcinog; 2007 Dec 13; 46(12):958-70. PubMed ID: 17477350
    [Abstract] [Full Text] [Related]

  • 15. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC, Tozer RG, Symons M, McCormick F, Hassell JA.
    Oncogene; 1996 Sep 19; 13(6):1323-33. PubMed ID: 8808707
    [Abstract] [Full Text] [Related]

  • 16. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC, Prorock-Rogers C, Kelly J, Dong Z, Lin JJ, Armstrong L, Kung HF, Weber MJ, Afonso A.
    Cancer Res; 1995 Nov 01; 55(21):5106-17. PubMed ID: 7585559
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN, Abramova MV, Svetlikova SB, Darieva ZA, Pospelova TV, Pospelov VA.
    Oncogene; 2002 Jan 24; 21(5):719-30. PubMed ID: 11850800
    [Abstract] [Full Text] [Related]

  • 18. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, Gutkind JS.
    Oncogene; 1996 Aug 01; 13(3):455-60. PubMed ID: 8760286
    [Abstract] [Full Text] [Related]

  • 19. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 20. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM, Oldham SM, Martin CB, Drugan JK, Zohn IE, Campbell S, Der CJ.
    Oncogene; 1999 Mar 25; 18(12):2107-16. PubMed ID: 10321735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.